Drug Trial Radar · NCT06377930
Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy
Last checked: Nov 19, 2026Latest source record: Feb 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
30
Actual
Start
Oct 10, 2024
Primary completion
Sep 26, 2025
Study completion Sep 26, 2025
Sponsor
- Lead sponsor
- Rapport Therapeutics Inc.Industry
- Sponsor type
- Industry
- First posted
- Apr 22, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a clinical research study for an investigational drug called RAP-219 in patients with Refractory Focal Epilepsy. This study is being conducted to determine if RAP-219 works and is safe in patients with Refractory Focal Epilepsy.
Conditions
- Focal Onset Seizures
Interventions
RAP-219Drug
RAP-219 oral tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in long episode frequency during the treatment period compared to pre-treatment baseline: Responder proportion, Percent Change Percent changeTime frame: Screening until 5 months after enrollment
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
Yale University
New Haven, Connecticut
Consultants in Epilepsy and Neurology, PLLC
Boise, Idaho
IU Health Neuroscience Center, Goodman Hall
Indianapolis, Indiana
The University of Kansas Medical Center Epilepsy Clinic
Kansas City, Kansas
Mayo Clinic
Rochester, Minnesota
NYU Langone Comprehensive Epilepsy Center
New York, New York
Cleveland Clinic Foundation
Cleveland, Ohio
University of Pennsylvania - Department of Neurology
Philadelphia, Pennsylvania
Thomas Jefferson University
Philadelphia, Pennsylvania
Vanderbilt University Medical Center
Nashville, Tennessee
Baylor College of Medicine
Houston, Texas
University of Texas Health Science Center, Houston
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.